Olodaterol/Glycopyrronium Bromide

奥达特罗/格隆溴铵

Report date: 2022/10/20 14:50:31
NME

Base Information

Drug NameOlodaterol/Glycopyrronium Bromide
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnovent Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnovent Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A